Inovio stock forecast 2025 refers to the predicted value of Inovio Pharmaceuticals’ (INO) stock in 2025. Stock forecasts are based on various factors such as the company’s financial performance, industry trends, and overall economic conditions.
Inovio is a clinical-stage biotechnology company focused on developing and commercializing DNA-based immunotherapies for infectious diseases and cancer. The company’s lead product candidate, INO-4800, is a DNA vaccine for COVID-19 that is currently in Phase 3 clinical trials. Inovio also has a pipeline of other DNA-based vaccines in development for various infectious diseases and cancer indications.
